Since June 2025, Labcorp has been in a holding pattern, posting a small return of 1% while floating around $258.38. The stock also fell short of the S&P 500’s 14.1% gain during that period. Is there a ...

In this article you are going to find out whether hedge funds think Laboratory Corp. of America Holdings (NYSE:LH) is a good investment right now. We like to check what the smart money thinks first ...

Laboratory Corporation has visible headwinds to growth ahead. The company's return on capital employed has lagged behind the required rate of return in the last two periods. Net-net, reiterate that LH ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Labcorp Holdings Inc. LH, or Labcorp, continues to expand its business in specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology. The company’s strategic ...

Hologic HOLX and Labcorp LH are two established MedTech players with a history of collaboration, though each brings distinct strengths. With a market capitalization of $16.71 billion, Hologic ...

Laboratory Corporation of America Holdings or LabCorp LH is well poised for growth in the coming quarters, backed by strength in the Covance Drug Development arm. The company’s plans to expand in high ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...